Clinical Trials Logo

Clinical Trial Summary

Cow milk allergy is one of the most frequent food allergy among children. Cow milk protein's avoidance is needed until spontaneous recovery during the two first years of life. A atypical clinical form with angio-oedema of hands and feet which is associated with high rate of lactoserum's IgE might be a hope of an earlier recovery.


Clinical Trial Description

Cow Milk allergy is one of the most frequent pediatric food allergy and occurs during the first months of life. It is due to an inappropriate reaction of immune system against the human body. Its treatment is the avoidance of the cow milk proteins. Its spontaneous recovery occurs mostly during the first years of life with the decreasing of the specific IgE and the clinical tolerance to cow milk proteins. Two shorts cas reports (3 and 5 patients) have described a clinical form of IgE-mediated cow milk allergy with angio-oedema of hands and feet. This clinical form is associated with more increasing of specific IgE against lactoserum proteins than caseine's. However it has been showed that casein is a marker of cow milk allergy persistence. It might be possible that this atypical form of cow milk allergy progresses favorably towards a restoration of tolerance earlier than the clinical form without angio-oedema of the extremities ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04318483
Study type Observational
Source Fondation Lenval
Contact
Status Completed
Phase
Start date May 4, 2020
Completion date May 3, 2021

See also
  Status Clinical Trial Phase
Completed NCT01950533 - The Utility of Food-Specific IgE Measured With the IMMULITE 2000 Assay to Predict Symptomatic Food Allergy
Completed NCT02579876 - Milk Patch for Eosinophilic Esophagitis Phase 2
Completed NCT02317952 - Formula for Children With Cow's Milk Allergy N/A
Completed NCT00968110 - Xolair Treatment for Milk Allergic Children Early Phase 1
Recruiting NCT03309488 - Basophil Activation Test to Diagnose Food Allergy
Completed NCT00328731 - Milk ALLERGY ELIMINATION THROUGH NAET® (Nambudripad's Allergy Elimination Techniques). Phase 1/Phase 2
Recruiting NCT05309772 - The Clinical Impact of the Basophil Activation Test to Diagnose Food Allergy N/A
Terminated NCT02719405 - Impact of Infant Formula on Resolution of Cow's Milk Allergy Phase 2
Completed NCT01361347 - Safety of Oral Immunotherapy for Cow's Milk Allergy in School-aged Children Phase 4
Completed NCT01157117 - OIT and Xolair® (Omalizumab) in Cow's Milk Allergy Phase 2
Active, not recruiting NCT00732654 - The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy Phase 1/Phase 2
Recruiting NCT03819556 - Swedish Study of Immunotherapy for Milk Allergy in Children N/A